arrow
E

Edgar Faber

olomouc university hospital and faculty of medicine and dentistry
H指数:23
被引数:2,313

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chronic myeloid leukaemia: have basophils gone the way of the Dodo bird?

慢性髓系白血病:嗜碱性粒细胞是否已走向灭绝?

Leukemia
IF13.4
2026-03-160
OAAI
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase

慢性髓性白血病急变期预后评分系统的开发

Leukemia
IF13.4
2026-02-190
OA
Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia

慢性髓性白血病诊断时额外染色体异常的临床及预后意义

2025-01-280
PRE
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial
LEUKEMIA
IF13.4
2024-07-102
PRE
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry
LEUKEMIA
IF13.4
2024-03-284
OAAI
Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF
LEUKEMIA
IF13.4
2024-03-120
OAAI
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors
2024-02-051
OAAI
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib

药物转运体OCTN1基因启动子中的SNP rs460089对伊马替尼治疗的慢性粒细胞白血病患者的无治疗缓解具有预后价值

LEUKEMIA
IF13.4
2023-12-213
OAAI
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia

CCR7作为t细胞幼淋巴细胞白血病的新治疗靶点

2020-10-2420
OAAI
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia
LEUKEMIA
IF13.4
2020-06-2945
OAAI
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin
2019-09-1420
OAAI
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
LEUKEMIA
IF13.4
2017-08-1479
PREAI
Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications
2013-07-235
OAAI